Lupă
Încărcător de căutare

Steven Julious & Say Beng Tan 
An Introduction to Statistics in Early Phase Trials 

Ajutor
All new medicines and devices undergo early phase trials to assess,
interpret and better understand their efficacy, tolerability and
safety. An Introduction to Statistics in Early Phase Trials
describes the practical design and analysis of these important
early phase clinical trials and provides the crucial statistical
basis for their interpretation. It clearly and concisely provides
an overview of the most common types of trials undertaken in early
phase clinical research and explains the different methodologies
used. The impact of statistical technologies on clinical
development and the statistical and methodological basis for making
clinical and investment decisions are also explained.

* Conveys key ideas in a concise manner understandable by
non-statisticians

* Explains how to optimise designs in a constrained or fixed
resource setting

* Discusses decision making criteria at the end of Phase II
trials

* Highlights practical day-to-day issues and reporting of early
phase trials

An Introduction to Statistics in Early Phase Trials is an
essential guide for all researchers working in early phase clinical
trial development, from clinical pharmacologists and
pharmacokineticists through to clinical investigators and medical
statisticians. It is also a valuable reference for teachers and
students of pharmaceutical medicine learning about the design and
analysis of clinical trials.
€91.99
Metode de plata

Cuprins

Chapter 1 Early phase trials 1

Chapter 2 Introduction to pharmacokinetics 13

Chapter 3 Sample size calculations for clinical trials 37

Chapter 4 Crossover trial basics 55

Chapter 5 Multi-period crossover trials 71

Chapter 6 First time into man 87

Chapter 7 Bayesian and frequentist methods 113

Chapter 8 First-time-into-new-population studies 125

Chapter 9 Bioequivalence studies 139

Chapter 10 Other Phase I trials 169

Chapter 11 Phase II trials: general issues 187

Chapter 12 Dose-response studies 197

Chapter 13 Phase II trials with toxic therapies 211

Chapter 14 Interpreting and applying early phase trial results 223

Chapter 15 Go/No-Go criteria 231

Appendix 245

References 251

Index 257

Despre autor

Steven A. Julious, Medical Statistics Group, School of Health and Related Research, University of Sheffield, UK.

Say-Beng Tan, Singapore Clinical Research Institute and Duke-NUS Graduate Medical School, Singapore.

David Machin, Children’s Cancer and Leukaemia Group (CCLG), University of Leicester, UK.
Limba Engleză ● Format PDF ● Pagini 264 ● ISBN 9780470319178 ● Mărime fișier 5.5 MB ● Editura John Wiley & Sons ● Publicat 2010 ● Ediție 1 ● Descărcabil 24 luni ● Valută EUR ● ID 2316217 ● Protecție împotriva copiilor Adobe DRM
Necesită un cititor de ebook capabil de DRM

Mai multe cărți electronice de la același autor (i) / Editor

140.191 Ebooks din această categorie